APA (7th ed.) Citation

GA, B., GM, C., G, R., SJ, H., S, M., M, B., . . . PE, P. (2025). A Phase 2 Clinical Trial of Oxylanthanum Carbonate in Patients Receiving Maintenance Hemodialysis with Hyperphosphatemia. Clinical journal of the American Society of Nephrology : CJASN, 20(9), 1259. https://doi.org/10.2215/CJN.0000000780

Chicago Style (17th ed.) Citation

GA, Block, Chertow GM, Reddy G, Hasal SJ, Mourya S, Block M, Gupta S, and Pergola PE. "A Phase 2 Clinical Trial of Oxylanthanum Carbonate in Patients Receiving Maintenance Hemodialysis with Hyperphosphatemia." Clinical Journal of the American Society of Nephrology : CJASN 20, no. 9 (2025): 1259. https://doi.org/10.2215/CJN.0000000780.

MLA (9th ed.) Citation

GA, Block, et al. "A Phase 2 Clinical Trial of Oxylanthanum Carbonate in Patients Receiving Maintenance Hemodialysis with Hyperphosphatemia." Clinical Journal of the American Society of Nephrology : CJASN, vol. 20, no. 9, 2025, p. 1259, https://doi.org/10.2215/CJN.0000000780.